• Home
  1. Home
  2. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Scientific article
OA Policy
English

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

ContributorsPrins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; Bounameaux, Henri; Brighton, Timothy A; Cohen, Alexander T; Davidson, Bruce L; Decousus, Hervé; Raskob, Gary E; Berkowitz, Scott D; Wells, Philip S
Published inThrombosis journal, vol. 11, no. 1, 21
Publication date2013
Abstract

Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of anticoagulant effects.

Affiliation entities
Research groups
Citation (ISO format)
PRINS, Martin H et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. In: Thrombosis journal, 2013, vol. 11, n° 1, p. 21. doi: 10.1186/1477-9560-11-21
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Additional URL for this publicationhttp://www.thrombosisjournal.com/content/11/1/21
Journal ISSN1477-9560
611views
757downloads

Technical informations

Creation27/09/2013 07:51:00
First validation27/09/2013 07:51:00
Update time27/01/2025 15:32:57
Status update27/01/2025 15:32:57
Last indexation27/01/2025 15:41:19
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack